Clock (Image 01)
Opill Tablet
Product Images NDC 0113-8101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Opill (NDC 0113-8101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by L. Perrigo Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Condom (Image 02)
Female-outline (Image 03)
An anatomical illustration of the female reproductive system, showing the uterus and ovaries. The diagram includes notes explaining how the drug Opill works: preventing egg release, blocking sperm by thickening cervical mucus, and noting that Opill does not prevent ovulation in all cycles. It also states the drug starts working from two days after beginning use.*
Tier-one (Image 04)
An instructional diagram illustrating four types of birth control methods: Implant, Female Sterilization, Vasectomy, and IUD. Each method is represented by a simple line drawing showing the device or anatomical area of application relevant to the contraceptive technique.*
Tier-two (Image 05)
An instructional diagram showing four contraceptive product types: injectable (depicted with a syringe and vial), pill (illustrated as a blister pack of tablets), patch (represented by a square), and ring (depicted as a circular ring). Each product type is labeled accordingly.*
Tiers (Image 06)
An instructional diagram illustrating various contraception methods. The image depicts male condom, female condom, withdrawal, diaphragm, sponge, spermicides, and fertility awareness-based methods, each with corresponding icons representing the method visually.*
Opill-pdp (Image 07)
Opill norgestrel tablets 0.075 mg daily oral contraceptive label showing a 28-tablet supply. The label indicates full prescription strength, FDA approval, and instructs to take one tablet daily while noting it is not for emergency contraception. Manufactured by Laboratoire HRA Pharma and distributed by PMI Branded Pharmaceuticals.*
Opill-dfl-one (Image 08)
Drug Facts panel for Opill norgestrel 0.075 mg oral contraceptive tablet by L. Perrigo Company. The text covers active ingredient, purpose, use, warnings including allergy and cancer risks, sexually transmitted disease alert, when to ask a doctor, seeking medical help, stop use instructions, keeping out of reach of children, and detailed directions for use with timing and additional precautions.*
Opill-dfl-two (Image 09)
Drug Facts panel for Opill (norgestrel) tablets displaying continued directions for use, instructions for missed doses, recommendations on condom use, and other important product information such as storage conditions and inactive ingredients. It includes a call-in phone number for questions or comments and tamper-evident packaging warnings.*
Reminder-card-front (Image 10)
Text panel reminding to take 1 Opill tablet at the same time every day without breaks, even during menstrual period changes. It advises using backup contraception for 2 days if a tablet is late or missed, with reference to the Drug Facts and consumer information leaflet for details.*
Reminder-card-back (Image 11)
Circular label for Opill norgestrel tablets 0.075 mg showing a reminder section for daily pill intake time (AM/PM). It includes adherence tips such as pairing tablet-taking with a daily task, keeping the pack visible, placing reminders in commonly seen locations, and setting a smartphone alarm. Labeler is L. Perrigo Company.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
